35794-11-7CC1CNCC(C)C1IDWRJRPUIXRFRX-UHFFFAOYSA-N35794-11-7DTXSID80865790Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.
Warning
H226 (100%): Flammable liquid and vapor [Warning Flammable liquids]
P210, P233, P240, P241, P242, P243, P261, P264, P264+P265, P271, P280, P302+P352, P303+P361+P353, P304+P340, P305+P351+P338, P319, P321, P332+P317, P337+P317, P362+P364, P370+P378, P403+P233, P403+P235, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 52 reports by companies from 9 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
Piperidine, 3,5-dimethyl- is listed on the EPA's Chemical Data Reporting (CDR) system. Manufacturers and importers of Piperidine, 3,5-dimethyl- are required to report information about their production and use of this chemical to the EPA under the Toxic Substances Control Act (TSCA). (40 eCFR Part 711)
REACH registered substance: 3,5-dimethylpiperidine (EC: 252-730-6)
Pharmaceutical and Medicine Manufacturing
Piperidine, 3,5-dimethyl-: ACTIVE
UsesReactant for synthesis of: Substituted bisphenol A derivatives as β-amyloid peptide aggregation inhibitors1 MMP-13 selective isonipecotamide α-sulfone hydroxamates2 Gem-diamines for active organocatalysts for biodiesel production3 Benzimidazole inhibitors of the antigen receptor-mediated NF-κB4 Reactant for Mannich reactions to form Ru(II) complexes5
UsesReactant for synthesis of: Substituted bisphenol A derivatives as β-amyloid peptide aggregation inhibitors MMP-13 selective isonipecotamide α-sulfone hydroxamates Gem-diamines for active organocatalysts for biodiesel production Benzimidazole inhibitors of the antigen receptor-mediated NF-κB Reactant for Mannich reactions to form Ru(II) complexes